Efficacy Lung function Patients receiving AB/FF demonstrated a greater reduction in adjusted mean change from baseline versus placebo in trough FRC at Week 4, but this did not reach statistical significance (0.125 L; P =0.069; Figure 3 ).
← all excerpts
ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD.
1
0.0690
0.0690